SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,911.01 31.61
( 0.04%)

Global Indices

Nasdaq

52,502.29 249.40
(0.48%)

Dow Jones

7,647.48 105.55
(1.40%)

Hang Seng

60,763.20 -485.39
(-0.79%)

Nikkei 225

10,863.06 27.59
(0.25%)

Forex

USD-INR

93.57 -0.21
(-0.22%)

EUR-INR

104.78 -0.12
(-0.12%)

GBP-INR

125.37 -0.34
(-0.27%)

JPY-INR

0.59 0.00
(-0.40%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

676.0910732

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

87.33

300380.35

EPS(TTM)

Face Value()

Div & Yield %

129.57

0.26

Back

divis laboratories ltd

Divi's Laboratories consolidated net profit rises 63.57% in the September 2026 quarter

Nov 07,2026

Net profit of Divi's Laboratories rose 63.57% to Rs 1127.00 crore in the quarter ended September 2026 as against Rs 689.00 crore during the previous quarter ended September 2025. Sales rose 35.40% to Rs 3676.00 crore in the quarter ended September 2026 as against Rs 2715.00 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	3676.00	2715.00	35
OPM %	42.60	32.71	-
PBDT	1647.00	1025.00	61
PBT	1505.00	912.00	65
NP	1127.00	689.00	64

81,911.01 31.61 ( 0.04%)

52,502.29 249.40 (0.48%)

7,647.48 105.55 (1.40%)

60,763.20 -485.39 (-0.79%)

10,863.06 27.59 (0.25%)

93.57 -0.21 (-0.22%)

104.78 -0.12 (-0.12%)

125.37 -0.34 (-0.27%)

0.59 0.00 (-0.40%)